Is reoperation for recurrence of glioblastoma justified?

Oncology Reports

Volumn 7, Issue 4, 2000, Pages 899-904

  Guyotat, Jacques ^a   Signorelli, Francesco ^a   Frappaz, Didier ^b   Madarassy, Gabore ^a   Ricci, Anne Claire ^a   Bret, Philippe ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

Glioblastoma multiforme; Karnofsky Performance Scale score; Recurrence; Reoperation

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN TUMOR; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; REOPERATION; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION; SURVIVAL RATE;

EID: 0034219456     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.4.899     Document Type: Article

References (32)

1. Walker MD, Strike TA and Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5: 1725-1731, 1979.
2. Fine HA, Dear KBG, Loeffer JS, Black PMcL and Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993.
3. Fine HA: The basis for current treatment recommendations for malignant gliomas. J Neurooncol 20: 111-120, 1994.
4. Devaux BC, O'Fallon JR and Kelly PJ: Resection biopsy and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy and outcome. J Neurosurg 78: 767-775, 1993.
5. Schackert G, Frank ST and Schackert HK: Gene therapy: approaches for the treatment of malignant gliomas: Onkologie 19: 16-22, 1996.
6. Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G and Kuurne T: Interstitial chemotherapy with Carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 41: 44-49, 1997.
7. Young B, Oldfield EH, Markesbery WR, Haack D, Tibbs PA, McCombs P, Chin HW, Maruyama Y and Meacham WF: Reoperation for glioblastoma. J Neurosurg 55: 917-921, 1981.
8. Ammirati M, Galicich JH, Arbit E and Liao Y: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21: 607-614, 1987.
9. Dirks P, Bernstein M, Muller PJ and Tucker WS: The value of reoperation for recurrent glioblastoma. Can J Surg 36: 271-275, 1993.
10. Harsh GR, Levin VA, Gutin PH, Seager M, Silver P and Wilson CHB: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21: 615-621, 1987.
11. Barker FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD and Wilson CHB: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42: 709-723, 1998.
12. Sipos L and Afra D: Re-operations of supratentorial anaplastic astrocytomas. Acta Neurochir 139: 99-104, 1997.
13. Davis FG, Freels S, Grutsch J, Barlas S and Brem S: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on surveillance, epidemiology, and end results (SEER) data, 1973-1991. J Neurosurg 88: 1-10, 1998.
14. Burger PC and Green SB: Patient age, histologic features and length of survival in patients with glioblastoma multiforme. Cancer 59: 1617-1625, 1987.
15. Bernard-Weil E: Evaluation of the addition to corticoids of a growth factor (vasopressin) in the palliative therapy of malignant brain tumours. Neural Res 13: 94-102, 1991.
16. Rostomily RC, Spence AM, Duong D, McCormick K, Bland M and Berger MS: Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 35: 378-388, 1994.
17. Poisson M, Chiras J, Fauchon F, Debussche C and Delattre JY: Treatment of malignant recurrent glioma by intra-arterial, infra-ophtalmic infusion of HECNU 1-(2-chlorethyl)-1-nitroso-3-(2-hydroxyethyl) urea: a phase II study. J Neurooncol 8: 255-262, 1990.
18. Yung WKA, Harris MI, Bruner JM and Feun LG: Intravenous BCNU and AZQ in patients with recurrent malignant gliomas. J Neurooncol 7: 237-240, 1989.
19. Gutin PH, Leibel SA, Wara WM, Choucair A, Levin VA, Phillips TL, Silver P, Da Silva V, Edwards MSB, Davis RL, Weaver KA and Lamb S: Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg 67: 864-873, 1987.
20. Siddiqi SN, Provias J, Laperriere N and Bernstein M: Effects of Iodine-125 brachytherapy on the proliferative capacity and histological features of glioblastoma recurring after initial therapy. Neurosurgery 40: 910-918, 1997.
21. Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons JP, Rohr M and Clark HB: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13: 1642-1648, 1995.
22. Vick NA, Ciric IS, Eller TW, Cozzens JW and Walsh A: Reoperation for malignant astrocytoma. Neurology 39: 430-432, 1989.
23. Berger MS, Tucker A, Spence A and Winn HR: Reoperation for glioma. Clin Neurosurg 39: 172-186, 1992.
24. Stromblad LG, Anderson H, Malmström P and Salford LG: Reoperation for malignant astrocytomas: personal experience and a review of the literature. Br J Neurosug 7: 623-633, 1993.
25. Durmaz R, Erken S, Arslantas A, Atasoy MA, Bal C and Tel E: Management of glioblastoma multiforme: with special reference to recurrence. Clin Neurol Neurosurg 99: 117-123, 1997.
26. Salcman M, Scholtz H, Kaplan RS and Kulik S: Long-term survival in patients with malignant astrocytoma. Neurosurgery 34: 213-220, 1994.
27. Mahaley MS, Mettlin C, Natarajan N, Laws ER Jr and Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826-836, 1989.
28. Salcman M, Kaplan RS, Ducker TB, Abdo H and Montgomery E: Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. Neurosurgery 10: 454-463, 1982.
29. Wallner KE, Galicich JH, Malkin MG, Arbit E, Krol G and Rosenblum MK: Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation. J Clin Oncol 7: 1492-1496, 1989.
30. Rostomily RC, Halligan JB, Keles GE, Spence AM and Berger MS: Management of adult recurrent supratentorial gliomas. Neurosurg Quart 3: 219-252, 1993.
31. Albert FK, Forsting M, Sartor K, Adams HP and Kunze S: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34: 45-60, 1994.
32. Becker G, Hofmann E, Woydt M, Hülsmann Y, Maurer M, Lindner A, Becker T and Krone A: Postoperative neuroimaging of high-grade gliomas: comparison of transcranial sonography, magnetic resonance imaging, and computed tomography. Neurosurgery 44: 469-478, 1999.